References
- Boanini E, Torricelli P, Gazzano M, Giardino R, Gigi A. Alendronate–hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells. Biomaterials 2008; 29: 790–96
- Boccaccini AR, Blaker JJ. Bioactive composite materials for tissue engineering scaffolds. Expert Rev Med Dev 2005; 2: 303–17
- Ezra A, Golomb G. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption. Adv Drug Del Rev 2000; 42: 175–95
- Gao Y, Zou S, Liu X, Bao C, Hu J. The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 2009; 30: 1790–96
- Hench LL, Polak JM. Third-generation biomedical materials. Science 2002; 295: 1014–17
- Koutsopoulos S, Synthesis and characterization of hydroxyapatite crystals: A review study on the analytical methods. Wiley Periodicals, Inc., 2002
- Lewis G. Hydroxyapatite-coated bioalloy surfaces: Current status and future challenges. Bio-Med. Mater Eng 2000; 10: 157–88
- Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63
- Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RGG, Ebetino FH. Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite. Bone 2006; 38: 617–27
- Neves M, Gano L, Pereira N, Costa MC, Costa MR, Chandia M, Rosado M, Fausto R. Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: Correlation with molecular modeling interaction studies. Nucl Med Biol 2002; 29: 329–38
- Palazzo B, Iafisco M, Laforgia M, Margiotta N, Natile G, Bianchi CL, Walsh D, Stephen M, Roveri R. Biomimetic hydroxyapatite-drug nanocrystals as potential bone substitutes with antitumor drug delivery properties. Adv Funct Mater 2007; 17: 2180–88
- Puleo DA, 2004. Bone-implant interface. Encyclopedia of Biomaterials and Biomedical Engineering. Vol. 1, 190–98
- Robinson J, Cukrowski I, Marques HM. Modelling the interaction of several bisphosphonates with hydroxyapatite using the generalised AMBER force field. J Mol Struct 2006; 825: 134–42
- Russell RGG, Rogers MJ. Biphosphonates: From the laboratory to the clinic and back again. Bone 1999; 25(1)97–106
- Seshima H, Yoshinari M, Takemoto S, Hattori M, Kawada E, Inoue T, Oda Y. Control of bisphosphonate release using hydroxyapatite granules. J Biomed Mater Res Part. B: Appl Biomater 2006; 78B: 215–21
- Shi X, Wang Y, Ren L, Gong Y, Wang DA. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric systems for bone repairing applications. Pharm Res 2009; 26(2)422–30
- Sienkiewicz B, Kowalski P, Ossowska K, Potok J, Cetina-Čizmek B, Tudja P, Danilovski, A. Solid-state form of alendronate sodium and preparation thereof. United States – Patent Application Publication, May 26, 2005, Pub no. US2005/0113343
- Taha EA, Youssef NF. Spectrophotometric determination of some drugs for osteoporosis. Chem Pharm Bull 2003; 51(12)1444–7
- Vasita R, Katti DS. Growth-factory delivery systems for tissue engineering: A materials perspective. Expert Rev Med Dev 2006; 3: 29–47
- Wang M. Developing bioactive composite materials for tissue replacement. Biomaterials 2003; 24: 2133–51